CCL4 antibody-treated mice had decreased levels of phosphorylated IRS-1 in both skeletal muscle and liver tissues compared to those in the untreated db/db mice (Figures 3E, F), implying the beneficial effects of CCL4 inhibition on improving insulin resistance. Here, IRS1 is linked to Insulin resistance.